News | Artificial Intelligence | November 25, 2019

Zebra Medical Vision Joins Forces with Nuance to Bring More AI to Diagnostic Imaging

Zebra-Med’s AI1 “all in one” bundle will be available on the Nuance AI Marketplace to support functions dedicated to radiology

Zebra Medical Vision announced that its AI1 “all-in-one” bundle of artificial intelligence (AI) products will be available on the Nuance AI Marketplace

November 25, 2019 — Zebra Medical Vision announced that its AI1 “all-in-one” bundle of artificial intelligence (AI) products will be available on the Nuance AI Marketplace. Nuance offers the first and largest portal with one-stop access to a wide range of AI diagnostic models.

The Nuance AI Marketplace functions like an app store that is dedicated to radiology. It provides algorithm developers consolidated, at-scale access to users of Nuance PowerScribe, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 6,500 connected healthcare facilities. Radiologists can discover, test, and use algorithms from within their familiar PowerScribe workflows, to increase reporting efficiency and quality, as well as help healthcare teams improve patient outcomes and healthcare costs. A built-in feedback channel lets users share real-world results with developers for algorithm refinement, and post-market surveillance. Hospital systems benefit with simplified purchasing and metrics showing algorithm usage, costs and performance.

As part of the Nuance AI Marketplace, Zebra Medical Vision will provide its AI1 “all-in-one” bundle, including access to an ever-growing number of AI solutions, integrated into radiologist workflow at an affordable, fixed annual fee. The company’s AI solutions analyze millions of clinical imaging in real time, detecting various medical indications, and alerting the relevant stakeholders in hospitals and clinics.

Zebra-Med’s AI1 introduced the new “all-in-one” bundle with a growing portfolio of AI solutions. The AI1 2020 version offers a wide range of products in three categories with the highest medical impact and patient outcome. The bundle will be launched at the upcoming RSNA conference, and will include some of the following solutions:

● Stat.AI: A multi-modality AI triage solution for the head CT package, in order to identify suspected intracranial hemorrhage (ICH), and a chest X-ray package for identifying suspected pneumothorax. Both products are FDA cleared and CE marked.

● Population Health:

  • ○ Bone Health package for identification of vertebral compression fractures which is key for indicating potential osteoporosis fractures, and serves bone health programs. CE marked.
  • ○ Cardiology — FDA cleared, automatic identification of coronary calcium.

● Oncology: Breast Cancer package with an automatic AI Triage mammography solution that indicates “suspicious” versus “non suspicious” for usage in diagnostic 2-D mammography. The mammo CAD solution is CE marked and the Triage solution is currently for investigational use only.

“We are thrilled that our software will now be available on the Nuance AI Marketplace,” said John LoGioco, CCO of Zebra Medical Vision. “This collaboration will give us maximum exposure on one of the largest and most reputable portals, with one-stop access to a wide range of AI diagnostic models. Our work with Nuance will enable Zebra-Med’s products to impact the health of many more patients, through the industry’s most widely used radiology reporting platform.”

For more information: www.zebra-med.comhttp://www.zebra-med.com

Related Content

Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology services, announced a number of steps it is taking as part of its aggressive transformational activity to position the company for long-term, sustainable growth
News | Radiology Business | June 05, 2020
June 5, 2020 — Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p
The opportunity to converge the silos of data into a cross-functional analysis can provide immense value during the COVID-19 outbreak and in the future

Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Jeff Vachon
In the midst of the coronavirus pandemic normal
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...